Jupiter Life Line Hospitals Limited Share Price & Analysis
₹1,307.5▼ -0.59%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹1,307.5
-0.59%
Open
₹—
High
₹1,325.3
Low
₹1,301.3
Close
₹1,307.5
52W High
₹1,625
52W Low
₹1,152
Volume
18K
Lot Size
1
Sector
Healthcare
Market Cap
₹9K Cr
Face Value
₹10
Mid Cap
Price Chart
Fundamentals
P/E
43.7
Sector P/E
48.9
P/B
5.54
EPS
₹28.77
ROE
13.6%
ROCE
15.4%
D/E Ratio
0.38
Div Yield
0.08%
Book Value
₹236
+
Strengths
- ✓Efficient capital deployment (ROCE 15.4%)
- ✓Low debt relative to equity (D/E 0.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
JLHL · as of Mar 2026
Promoters40.91%
FII9.77%▼0.27
DII15.82%▲0.18
Public33.51%▲0.08
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FII | 4.17% | 6.06% | 8.84% | 10.04% | 10.04% | 9.77% |
| DII | 14.16% | 13.85% | 13.46% | 15.75% | 15.64% | 15.82% |
| Public | 40.76% | 39.18% | 36.79% | 33.31% | 33.43% | 33.51% |
Corporate Events
Interim Dividend - Re 1 Per Share
Dividend21 May 2026
To consider and approve the financial results for the period ended March 31, 2026
Results14 May 2026
Dividend - Re 1 Per Share
Dividend3 Jul 2025
Dividend - Re 1 Per Share
Dividend1 Aug 2024
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹365 Cr ▼7.4% | ₹394 Cr ▲11.6% | ₹353 Cr ▲4.7% | ₹337 Cr ▲1.2% | ₹333 Cr ▼0.6% | ₹335 Cr ▲15.9% | ₹289 Cr ▼0.7% | ₹291 Cr |
| Op. Profit | ₹83 Cr ▼9.8% | ₹92 Cr ▲17.9% | ₹78 Cr ▼2.5% | ₹80 Cr ▲5.3% | ₹76 Cr ▼2.6% | ₹78 Cr ▲20.0% | ₹65 Cr ▲3.2% | ₹63 Cr |
| OPM | 23.0% ▲0.0% | 23.0% ▲4.5% | 22.0% ▼8.3% | 24.0% ▲4.3% | 23.0% ▲0.0% | 23.0% ▲0.0% | 23.0% ▲4.5% | 22.0% |
| Net Profit | ₹42 Cr ▼26.3% | ₹57 Cr ▲29.5% | ₹44 Cr ▼2.2% | ₹45 Cr ▼13.5% | ₹52 Cr ▲0.0% | ₹52 Cr ▲15.6% | ₹45 Cr ▲0.0% | ₹45 Cr |
| EPS (₹) | 6.49 ▼25.8% | 8.75 ▲30.8% | 6.69 ▼2.9% | 6.89 ▼13.2% | 7.94 ▲0.8% | 7.88 ▲16.2% | 6.78 ▼1.3% | 6.87 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹1.5K Cr ▲18.9% | ₹1.3K Cr ▲17.6% | ₹1.1K Cr ▲20.2% | ₹893 Cr ▲21.8% | ₹733 Cr ▲50.8% | ₹486 Cr ▲5.0% | ₹463 Cr |
| Expenses | ₹1.2K Cr ▲19.9% | ₹965 Cr ▲16.1% | ₹831 Cr ▲20.3% | ₹691 Cr ▲19.1% | ₹580 Cr ▲38.4% | ₹419 Cr ▲10.6% | ₹379 Cr |
| Op. Profit | ₹343 Cr ▲15.5% | ₹297 Cr ▲22.7% | ₹242 Cr ▲20.4% | ₹201 Cr ▲31.4% | ₹153 Cr ▲128.4% | ₹67 Cr ▼20.2% | ₹84 Cr |
| OPM | 23.0% ▼4.2% | 24.0% ▲4.3% | 23.0% ▲0.0% | 23.0% ▲9.5% | 21.0% ▲50.0% | 14.0% ▼22.2% | 18.0% |
| Other Income | ₹37 Cr ▲27.6% | ₹29 Cr ▲31.8% | ₹22 Cr ▲175.0% | ₹8 Cr ▲100.0% | ₹4 Cr ▲0.0% | ₹4 Cr | ₹0 Cr |
| Interest | ₹33 Cr ▲200.0% | ₹11 Cr ▼57.7% | ₹26 Cr ▼38.1% | ₹42 Cr ▼4.5% | ₹44 Cr ▲12.8% | ₹39 Cr ▲50.0% | ₹26 Cr |
| Depreciation | ₹88 Cr ▲54.4% | ₹57 Cr ▲35.7% | ₹42 Cr ▲7.7% | ₹39 Cr ▲8.3% | ₹36 Cr ▲16.1% | ₹31 Cr ▲19.2% | ₹26 Cr |
| PBT | ₹260 Cr ▲0.8% | ₹258 Cr ▲32.3% | ₹195 Cr ▲51.2% | ₹129 Cr ▲67.5% | ₹77 Cr ▲3750.0% | ₹2 Cr ▼93.9% | ₹33 Cr |
| Tax % | 25.0% ▲0.0% | 25.0% ▲150.0% | 10.0% ▼76.7% | 43.0% ▲26.5% | 34.0% ▼86.3% | 248.0% ▲2380.0% | 10.0% |
| Net Profit | ₹194 Cr ▲0.0% | ₹194 Cr ▲9.6% | ₹177 Cr ▲142.5% | ₹73 Cr ▲43.1% | ₹51 Cr ▲2650.0% | ₹-2 Cr ▼106.7% | ₹30 Cr |
| EPS (₹) | 29.59 ▲0.3% | 29.51 ▲9.5% | 26.94 ▲108.8% | 12.9 ▲28.4% | 10.05 ▲2333.3% | -0.45 ▼107.7% | 5.83 |
| Div Payout | 3.0% ▲0.0% | 3.0% ▼25.0% | 4.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹66 Cr ▲0.0% | ₹66 Cr ▲0.0% | ₹66 Cr ▲0.0% | ₹66 Cr ▲15.8% | ₹57 Cr ▲11.8% | ₹51 Cr ▲0.0% | ₹51 Cr ▲0.0% | ₹51 Cr |
| Reserves | ₹1.5K Cr ▲6.8% | ₹1.4K Cr ▲7.3% | ₹1.3K Cr ▲17.0% | ₹1.1K Cr ▲257.0% | ₹309 Cr ▲27.2% | ₹243 Cr ▲29.3% | ₹188 Cr ▲1.1% | ₹186 Cr |
| Borrowings | ₹584 Cr ▲44.9% | ₹403 Cr ▲2.5% | ₹393 Cr | ₹0 Cr ▼100.0% | ₹469 Cr ▼5.3% | ₹495 Cr ▲16.2% | ₹426 Cr ▲56.6% | ₹272 Cr |
| Other Liabilities | ₹255 Cr ▲51.8% | ₹168 Cr ▲8.4% | ₹155 Cr ▲38.4% | ₹112 Cr ▼25.8% | ₹151 Cr ▲25.8% | ₹120 Cr ▼3.2% | ₹124 Cr ▲31.9% | ₹94 Cr |
| Total Liabilities | ₹2.4K Cr ▲17.8% | ₹2.0K Cr ▲6.2% | ₹1.9K Cr ▲48.7% | ₹1.3K Cr ▲29.9% | ₹986 Cr ▲8.5% | ₹909 Cr ▲15.2% | ₹789 Cr ▲30.8% | ₹603 Cr |
| Assets | ||||||||
| Fixed Assets | ₹1.4K Cr ▲38.7% | ₹998 Cr ▲2.1% | ₹977 Cr ▲36.1% | ₹718 Cr ▼0.3% | ₹720 Cr ▲5.3% | ₹684 Cr ▲8.6% | ₹630 Cr ▲44.8% | ₹435 Cr |
| CWIP | ₹129 Cr ▼56.4% | ₹296 Cr ▲60.0% | ₹185 Cr ▲150.0% | ₹74 Cr ▲155.2% | ₹29 Cr ▲7.4% | ₹27 Cr ▲3.8% | ₹26 Cr ▲160.0% | ₹10 Cr |
| Investments | ₹486 Cr ▼7.6% | ₹526 Cr ▲361.4% | ₹114 Cr ▲570.6% | ₹17 Cr ▲750.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▼57.1% | ₹7 Cr ▲250.0% | ₹2 Cr |
| Other Assets | ₹384 Cr ▲89.2% | ₹203 Cr ▼67.7% | ₹628 Cr ▲32.8% | ₹473 Cr ▲101.3% | ₹235 Cr ▲20.5% | ₹195 Cr ▲54.8% | ₹126 Cr ▼19.2% | ₹156 Cr |
| Total Assets | ₹2.4K Cr ▲17.8% | ₹2.0K Cr ▲6.2% | ₹1.9K Cr ▲48.7% | ₹1.3K Cr ▲29.9% | ₹986 Cr ▲8.5% | ₹909 Cr ▲15.2% | ₹789 Cr ▲30.8% | ₹603 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹268 Cr ▲5.9% | ₹253 Cr ▲120.0% | ₹115 Cr ▼34.7% | ₹176 Cr ▲28.5% | ₹137 Cr ▲11.4% | ₹123 Cr ▲66.2% | ₹74 Cr |
| Investing CF | ₹-442 Cr ▼111.5% | ₹-209 Cr ▲15.0% | ₹-246 Cr ▼161.7% | ₹-94 Cr ▼11.9% | ₹-84 Cr ▲71.5% | ₹-295 Cr ▼586.0% | ₹-43 Cr |
| Financing CF | ₹136 Cr ▼54.8% | ₹301 Cr ▲135.2% | ₹128 Cr ▲351.0% | ₹-51 Cr ▼259.4% | ₹32 Cr ▼82.6% | ₹184 Cr ▲675.0% | ₹-32 Cr |
| Net Cash Flow | ₹-38 Cr ▼111.0% | ₹345 Cr ▲11600.0% | ₹-3 Cr ▼109.7% | ₹31 Cr ▼63.5% | ₹85 Cr ▲608.3% | ₹12 Cr ▲1300.0% | ₹-1 Cr |
| Free Cash Flow | ₹-234 Cr ▼249.3% | ₹-67 Cr ▼331.0% | ₹29 Cr ▼71.0% | ₹100 Cr ▲117.4% | ₹46 Cr ▲139.0% | ₹-118 Cr ▼356.5% | ₹46 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 18d ▲50.0% | 12d ▼36.8% | 19d ▲0.0% | 19d ▲35.7% | 14d ▼12.5% | 16d ▼54.3% | 35d |
| Inventory Days | 49d ▲28.9% | 38d ▼7.3% | 41d ▼6.8% | 44d ▲12.8% | 39d ▼18.8% | 48d ▼25.0% | 64d |
| Days Payable | 121d ▼25.8% | 163d ▲35.8% | 120d ▼26.8% | 164d ▲4.5% | 157d ▼27.6% | 217d ▼19.0% | 268d |
| Cash Conv. Cycle | -54d ▲52.2% | -113d ▼91.5% | -59d ▲41.6% | -101d ▲2.9% | -104d ▲31.6% | -152d ▲10.1% | -169d |
| Working Capital Days | 97d ▲585.0% | -20d ▼300.0% | -5d ▲79.2% | -24d ▲0.0% | -24d ▼242.9% | -7d ▼141.2% | 17d |
| ROCE | 15.0% ▼16.7% | 18.0% ▼18.2% | 22.0% ▲4.8% | 21.0% ▲23.5% | 17.0% ▲142.9% | 7.0% | — |
Source: Screener.in · Lower days = better efficiency
About Jupiter Life Line Hospitals Limited
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Jupiter Life Line Hospitals Limited share price today?▾
Jupiter Life Line Hospitals Limited (JLHL) is currently trading at ₹1,307.5 on NSE, down 0.59% as of the last market session. Prices update daily after market close on MarketNetra.
Is Jupiter Life Line Hospitals Limited available in F&O (Futures & Options)?▾
Yes, Jupiter Life Line Hospitals Limited (JLHL) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Jupiter Life Line Hospitals Limited 52-week high and low?▾
Jupiter Life Line Hospitals Limited's 52-week high is ₹1,625 and the 52-week low is ₹1,152. The current price of ₹1,307.5 is 19.5% below the 52W high.
What is Jupiter Life Line Hospitals Limited P/E ratio?▾
Jupiter Life Line Hospitals Limited's current P/E ratio is 43.7. This indicates the market is paying ₹43.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Jupiter Life Line Hospitals Limited options?▾
Jupiter Life Line Hospitals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade JLHL options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.